In Yekaterinburg will test a new drug against HIV

Research will be conducted and in other cities Russian Federation. Ministry of Health of the Russian Federation gave out permission to carrying out a 2b-phase of clinical trials of a new preparation for people with HIV. To it testify given the register of clinical trials of department. "The purpose of clinical trial – an efficiency assessment, safety, shipping and a profile of resistance of the preparation GSK3640254 in a combination with dolutegraviry in comparison with a combination dolutegravira and lamivudina at VICh-1 of the infected adults who earlier were not receiving treatment", – it is spoken in the register. Tests will be carried out by ViiV Healthcare UK Ltd in nine...